Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-5
pubmed:abstractText
In a randomized trial with a median follow-up of 18.4 months, 6 months of induction chemotherapy with a three-drug regimen comprising 5-fluorouracil (by continuous infusion)-leucovorin, irinotecan, and oxaliplatin (FOLFOXIRI) demonstrated statistically significant improvements in response rate, radical surgical resection of metastases, progression-free survival, and overall survival compared with 6 months of induction chemotherapy with fluorouracil-leucovorin and irinotecan (FOLFIRI).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1460-2105
pubmed:author
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21-30
pubmed:meshHeading
pubmed-meshheading:21123833-Adult, pubmed-meshheading:21123833-Aged, pubmed-meshheading:21123833-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21123833-Camptothecin, pubmed-meshheading:21123833-Colorectal Neoplasms, pubmed-meshheading:21123833-Disease-Free Survival, pubmed-meshheading:21123833-Female, pubmed-meshheading:21123833-Fluorouracil, pubmed-meshheading:21123833-Follow-Up Studies, pubmed-meshheading:21123833-Humans, pubmed-meshheading:21123833-Infusions, Intravenous, pubmed-meshheading:21123833-Kaplan-Meier Estimate, pubmed-meshheading:21123833-Leucovorin, pubmed-meshheading:21123833-Male, pubmed-meshheading:21123833-Middle Aged, pubmed-meshheading:21123833-Multivariate Analysis, pubmed-meshheading:21123833-Neoplasm Staging, pubmed-meshheading:21123833-Organoplatinum Compounds, pubmed-meshheading:21123833-Proportional Hazards Models, pubmed-meshheading:21123833-Remission Induction, pubmed-meshheading:21123833-Sample Size, pubmed-meshheading:21123833-Treatment Outcome
pubmed:year
2011
pubmed:articleTitle
Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.
pubmed:affiliation
U.O. Oncologia Medica 2 Universitaria - Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Via Roma, 67 - 56126 Pisa, Italy. a.falcone@med.unipi.it
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't